Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) filed a Form 8-K with the Securities and Exchange Commission on January 14, 2026, disclosing a material event. Kiniksa…
Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) filed a Form 8-K with the Securities and Exchange Commission on January 14, 2026, disclosing a material event.
Kiniksa Pharmaceuticals International, plc's stock currently trades at $0.00 with a market capitalization of $0. The company's stock moved following the disclosure.
Our Markets Team monitors market data, SEC filings, analyst actions, earnings releases, and corporate announcements to produce timely updates for investors.
Current market data
NASDAQ · KNSA
$79.80
Up: +$1.12 · +1.42%
Live quote updated
Keep reading
analyst ·
sec_filing ·
earnings ·
analyst ·
